Advertisement
Screener

STERIS plc (STE) Accumulated Other Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

STERIS plc Accumulated Other Comprehensive Income

STERIS plc (STE) had Accumulated Other Comprehensive Income of -$127.30 million as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-07

  • 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$127.30M.
  • 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$113.10M.
  • 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$42.70M.
  • 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$76.10M.
Period endAccumulated Other Comprehensive Income (Loss), Net of TaxAccumulated Other Comprehensive Income (Loss), Net of Tax as first filed
2026-06-30-$127.30M
10-Q · filed 2026-08-07
2026-03-31-$113.10M
10-Q · filed 2026-08-07
2025-12-31-$42.70M
10-Q · filed 2026-02-06
2025-09-30-$76.10M
10-Q · filed 2025-11-06
2025-06-30-$70.50M
10-Q · filed 2025-08-07
2025-03-31-$292.30M
10-K · filed 2026-05-29
-$292.34M
10-K · filed 2025-05-29
2024-12-31-$374.25M
10-Q · filed 2025-02-07
2024-09-30-$165.84M
10-Q · filed 2025-02-07
2024-06-30-$323.07M
10-Q · filed 2024-11-07
2024-03-31-$328.70M
10-K · filed 2026-05-29
-$328.66M
10-K · filed 2024-05-29
2023-12-31-$252.63M
10-Q · filed 2025-02-07
2023-09-30-$386.74M
10-Q · filed 2025-02-07
2023-06-30-$310.86M
10-Q · filed 2024-11-07
2023-03-31-$320.70M
10-K · filed 2026-05-29
-$320.71M
10-K · filed 2023-05-26
2022-12-31-$364.16M
10-Q · filed 2024-02-08
2022-09-30-$598.15M
10-Q · filed 2024-02-08
2022-06-30-$388.37M
10-Q · filed 2023-11-07
2022-03-31-$209.81M
10-K · filed 2025-05-29
2021-12-31-$136.88M
10-Q · filed 2023-02-08
2021-09-30-$105.73M
10-Q · filed 2023-02-08
2021-06-30-$36.82M
10-Q · filed 2022-11-09
2021-03-31-$61.24M
10-K · filed 2024-05-29
2020-12-31-$2.39M
10-Q · filed 2022-02-09
2020-09-30-$130.61M
10-Q · filed 2022-02-09
2020-06-30-$208.35M
10-Q · filed 2021-11-08
2020-03-31-$235.46M
10-K · filed 2023-05-26
2019-12-31-$148.92M
10-Q · filed 2021-02-09
2019-09-30-$225.72M
10-Q · filed 2021-02-09
2019-06-30-$156.84M
10-Q · filed 2020-11-06
2019-03-31-$159.78M
10-K · filed 2022-05-31
2018-12-31-$167.03M
10-Q · filed 2020-02-10
2018-09-30-$126.78M
10-Q · filed 2020-02-10
2018-06-30-$121.10M
10-Q · filed 2019-11-07
2018-03-31$11.69M
10-K · filed 2021-05-28
2017-03-31-$240.70M
8-K · filed 2021-02-09
2016-03-31-$68.16M
10-K · filed 2019-05-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B